Zeria Pharmaceutical Subsidiary to Acquire Equity Interests in Haupt Pharma Wulfling
Zeria Pharmaceutical disclosed that a consolidated subsidiary will acquire equity interests in Haupt Pharma Wulfling GmbH, making it a sub-subsidiary.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.